Two RCTs reported cannabis use outcomes
following pharmacological interventions: one in people with major depression, alcohol dependence and cannabis abuse diagnoses (n = 22; fluoxetine vs placebo) and one in people with schizophrenia and cannabis and / or cocaine use disorders (n = 28; olanzapine vs risperidone).
Not exact matches
In the
following sections, we first provide an overview of treatment effects of non-
pharmacological and common
pharmacological treatments compared with inactive
interventions.
The reviews and meta - analyses addressed anxiety disorders (n = 42), depressive disorders (n = 48), and / or personality disorders (n = 13), and allowed conclusions about the
following interventions: 59 reviews compared psychological therapies with other forms of psychological therapies, and 36 compared psychological therapies with
pharmacological interventions.